CODX Latest Press Releases

-- December 30, 2025 --

Co-Diagnostics Announces Reverse Stock Split PRNewswire 9:00 AM

-- December 29, 2025 --

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies PRNewswire 9:00 AM

-- December 18, 2025 --

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India PRNewswire 9:00 AM

-- December 17, 2025 --

Co-Diagnostics Performs Analysis of Influenza Co-Primers to Confirm Reactivity Against Flu A H3N2 Mutation PRNewswire 9:00 AM

-- December 9, 2025 --

Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025 PRNewswire 9:01 AM

-- December 8, 2025 --

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India PRNewswire 12:37 PM

-- November 20, 2025 --

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health PRNewswire 9:01 AM

-- November 18, 2025 --

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA PRNewswire 9:00 AM

-- November 13, 2025 --

Co-Diagnostics Reports Third Quarter 2025 Financial Results PRNewswire 4:01 PM

-- November 12, 2025 --

Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia PRNewswire 9:00 AM

-- November 5, 2025 --

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd PRNewswire 9:00 AM

-- November 3, 2025 --

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx Primer Ai Platform PRNewswire 9:00 AM

-- October 31, 2025 --

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast PRNewswire 9:00 AM

-- October 30, 2025 --

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia PRNewswire 1:58 PM

-- October 29, 2025 --

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules PRNewswire 12:52 PM

-- October 28, 2025 --

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules PRNewswire 9:34 AM

-- October 27, 2025 --

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx PCR Platform Across the Middle East PRNewswire 8:45 AM

-- October 22, 2025 --

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia PRNewswire 8:30 AM

-- October 16, 2025 --

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing PRNewswire 9:30 AM

-- October 13, 2025 --

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit PRNewswire 9:30 AM

-- September 30, 2025 --

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 PRNewswire 9:30 AM

-- September 18, 2025 --

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules PRNewswire 5:05 PM

-- September 17, 2025 --

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules PRNewswire 9:47 AM

-- September 16, 2025 --

Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx PCR Platform to Middle East PRNewswire 9:30 AM

-- September 11, 2025 --

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers to Confirm Reactivity Against Known Virus Strains PRNewswire 9:30 AM

-- September 9, 2025 --

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit PRNewswire 9:30 AM

-- August 18, 2025 --

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C. PRNewswire 9:30 AM

-- August 14, 2025 --

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results PRNewswire 4:01 PM